CN115701422B - Preparation method of KGP94 - Google Patents
Preparation method of KGP94 Download PDFInfo
- Publication number
- CN115701422B CN115701422B CN202110879143.4A CN202110879143A CN115701422B CN 115701422 B CN115701422 B CN 115701422B CN 202110879143 A CN202110879143 A CN 202110879143A CN 115701422 B CN115701422 B CN 115701422B
- Authority
- CN
- China
- Prior art keywords
- benzophenone
- bromo
- reaction
- formula
- methoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- ZDBKSZKTCPOBFR-GHRIWEEISA-N [(z)-[(3-bromophenyl)-(3-hydroxyphenyl)methylidene]amino]thiourea Chemical compound C=1C=CC(Br)=CC=1C(=N/NC(=S)N)\C1=CC=CC(O)=C1 ZDBKSZKTCPOBFR-GHRIWEEISA-N 0.000 title claims abstract description 36
- 238000002360 preparation method Methods 0.000 title claims abstract description 20
- YJQLWOJNDBFINH-UHFFFAOYSA-N (3-bromophenyl)-(3-methoxyphenyl)methanone Chemical compound COC1=CC=CC(C(=O)C=2C=C(Br)C=CC=2)=C1 YJQLWOJNDBFINH-UHFFFAOYSA-N 0.000 claims abstract description 34
- 238000010520 demethylation reaction Methods 0.000 claims abstract description 32
- -1 amide compound Chemical class 0.000 claims abstract description 27
- 238000000034 method Methods 0.000 claims abstract description 24
- PBOOZQFGWNZNQE-UHFFFAOYSA-N 3-bromobenzoyl chloride Chemical compound ClC(=O)C1=CC=CC(Br)=C1 PBOOZQFGWNZNQE-UHFFFAOYSA-N 0.000 claims abstract description 12
- FKUUDDGRDRPAQQ-UHFFFAOYSA-M magnesium;methoxybenzene;bromide Chemical compound [Mg+2].[Br-].COC1=CC=C[C-]=C1 FKUUDDGRDRPAQQ-UHFFFAOYSA-M 0.000 claims abstract description 11
- ILAHWRKJUDSMFH-UHFFFAOYSA-N boron tribromide Chemical compound BrB(Br)Br ILAHWRKJUDSMFH-UHFFFAOYSA-N 0.000 claims description 40
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims description 34
- 238000006482 condensation reaction Methods 0.000 claims description 25
- 150000001875 compounds Chemical class 0.000 claims description 20
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 20
- JWAONYKLAUBMBH-UHFFFAOYSA-N (3-bromophenyl)-(3-hydroxyphenyl)methanone Chemical compound OC1=CC=CC(C(=O)C=2C=C(Br)C=CC=2)=C1 JWAONYKLAUBMBH-UHFFFAOYSA-N 0.000 claims description 17
- 238000010534 nucleophilic substitution reaction Methods 0.000 claims description 15
- 238000005859 coupling reaction Methods 0.000 claims description 13
- BRWIZMBXBAOCCF-UHFFFAOYSA-N hydrazinecarbothioamide Chemical compound NNC(N)=S BRWIZMBXBAOCCF-UHFFFAOYSA-N 0.000 claims description 12
- USZLCYNVCCDPLQ-UHFFFAOYSA-N hydron;n-methoxymethanamine;chloride Chemical compound Cl.CNOC USZLCYNVCCDPLQ-UHFFFAOYSA-N 0.000 claims description 10
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 10
- 238000006555 catalytic reaction Methods 0.000 claims description 5
- 238000003786 synthesis reaction Methods 0.000 abstract description 7
- 230000017858 demethylation Effects 0.000 abstract description 4
- 238000009833 condensation Methods 0.000 abstract description 3
- 230000005494 condensation Effects 0.000 abstract description 3
- 150000001408 amides Chemical class 0.000 abstract description 2
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 57
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 36
- 239000000243 solution Substances 0.000 description 25
- 239000012074 organic phase Substances 0.000 description 21
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 20
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 20
- 238000006243 chemical reaction Methods 0.000 description 20
- 239000003960 organic solvent Substances 0.000 description 14
- 239000008346 aqueous phase Substances 0.000 description 10
- 239000003208 petroleum Substances 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 8
- 238000000605 extraction Methods 0.000 description 8
- 239000012295 chemical reaction liquid Substances 0.000 description 7
- 238000004440 column chromatography Methods 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 238000012805 post-processing Methods 0.000 description 7
- SRVJKTDHMYAMHA-WUXMJOGZSA-N thioacetazone Chemical compound CC(=O)NC1=CC=C(\C=N\NC(N)=S)C=C1 SRVJKTDHMYAMHA-WUXMJOGZSA-N 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 6
- 238000005160 1H NMR spectroscopy Methods 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 238000001035 drying Methods 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 5
- 239000012267 brine Substances 0.000 description 5
- 239000005457 ice water Substances 0.000 description 5
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 238000001228 spectrum Methods 0.000 description 5
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 4
- 239000002274 desiccant Substances 0.000 description 4
- KJIFKLIQANRMOU-UHFFFAOYSA-N oxidanium;4-methylbenzenesulfonate Chemical compound O.CC1=CC=C(S(O)(=O)=O)C=C1 KJIFKLIQANRMOU-UHFFFAOYSA-N 0.000 description 4
- 230000035484 reaction time Effects 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 239000003513 alkali Substances 0.000 description 3
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 3
- 230000002596 correlated effect Effects 0.000 description 3
- 239000003599 detergent Substances 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000012265 solid product Substances 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 229910052786 argon Inorganic materials 0.000 description 2
- 239000012965 benzophenone Substances 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 238000005100 correlation spectroscopy Methods 0.000 description 2
- 230000001335 demethylating effect Effects 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000000171 quenching effect Effects 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- VIDYVRMUWBNYCT-UHFFFAOYSA-N (benzhydrylideneamino)thiourea Chemical class C=1C=CC=CC=1C(=NNC(=S)N)C1=CC=CC=C1 VIDYVRMUWBNYCT-UHFFFAOYSA-N 0.000 description 1
- 102000005600 Cathepsins Human genes 0.000 description 1
- 108010084457 Cathepsins Proteins 0.000 description 1
- 101100391174 Dictyostelium discoideum forC gene Proteins 0.000 description 1
- 239000007818 Grignard reagent Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 229940125782 compound 2 Drugs 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000006880 cross-coupling reaction Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000010511 deprotection reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000000132 electrospray ionisation Methods 0.000 description 1
- 238000004896 high resolution mass spectrometry Methods 0.000 description 1
- 150000002466 imines Chemical class 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 208000037819 metastatic cancer Diseases 0.000 description 1
- 208000011575 metastatic malignant neoplasm Diseases 0.000 description 1
- SKTCDJAMAYNROS-UHFFFAOYSA-N methoxycyclopentane Chemical compound COC1CCCC1 SKTCDJAMAYNROS-UHFFFAOYSA-N 0.000 description 1
- 238000005009 overhauser spectroscopy Methods 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000012286 potassium permanganate Substances 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- CZDYPVPMEAXLPK-UHFFFAOYSA-N tetramethylsilane Chemical compound C[Si](C)(C)C CZDYPVPMEAXLPK-UHFFFAOYSA-N 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
技术领域Technical field
本发明涉及有机合成技术领域,特别涉及一种KGP94的制备方法。The present invention relates to the technical field of organic synthesis, and in particular to a preparation method of KGP94.
背景技术Background technique
KGP94是一种选择性、高活性((IC50=131.4μM)、低毒性((GI50=26.9μM))的组织蛋白酶小分子抑制剂,属于取代苯甲酮缩氨基硫脲类化合物。KGP94针对转移性癌症的治疗,目前正处于临床前研究且备受关注。KGP94 is a selective, highly active ((IC 50 =131.4μM), low toxicity ((GI 50 =26.9μM)) small molecule inhibitor of cathepsin, which belongs to the substituted benzophenone thiosemicarbazone compounds. KGP94 The treatment of metastatic cancer is currently in preclinical research and attracts much attention.
目前,已报道的KGP94的合成方法主要有两种。第一种方法的合成路线如下:Currently, there are two main reported synthesis methods of KGP94. The synthesis route of the first method is as follows:
第二种方法在第一种方法的基础上,做出了改进,合成路线如下:The second method is improved on the basis of the first method. The synthesis route is as follows:
已报到的这两种方法均以交叉偶联反应为关键步骤,经氧化、缩合、去保护,最终得到目标物,但都存在着合成路线较长、总收率低的缺陷。The two reported methods both use cross-coupling reaction as the key step, and finally obtain the target compound through oxidation, condensation, and deprotection. However, they both have the shortcomings of long synthetic routes and low overall yields.
发明内容Contents of the invention
有鉴于此,本发明目的在于提供一种KGP94的制备方法。本发明提供的制备方法合成路线短,总收率高。In view of this, the purpose of the present invention is to provide a preparation method of KGP94. The preparation method provided by the invention has a short synthesis route and high overall yield.
为了实现上述发明目的,本发明提供以下技术方案:In order to achieve the above-mentioned object of the invention, the present invention provides the following technical solutions:
本发明提供了一种KGP94的制备方法,包括以下步骤:The invention provides a preparation method of KGP94, which includes the following steps:
(1)在碳酸钾催化下,3-溴苯甲酰氯与N,O-二甲基羟胺盐酸盐进行亲核取代反应,得到具有式1所示结构的酰胺化合物:(1) Under the catalysis of potassium carbonate, 3-bromobenzoyl chloride and N,O-dimethylhydroxylamine hydrochloride undergo nucleophilic substitution reaction to obtain an amide compound with the structure shown in Formula 1:
(2)3-甲氧基苯基溴化镁与具有式1所示结构的酰胺化合物进行偶联反应,得到3-溴-3'-甲氧基-二苯甲酮;(2) 3-Methoxyphenylmagnesium bromide is coupled with an amide compound having the structure shown in Formula 1 to obtain 3-bromo-3'-methoxy-benzophenone;
(3)3-溴-3'-甲氧基-二苯甲酮进行第一路线或第二路线,得到KGP94;(3) 3-bromo-3'-methoxy-benzophenone is subjected to the first route or the second route to obtain KGP94;
所述第一路线包括:与氨基硫脲、对甲苯磺酸进行第一缩合反应,得到具有式2所示结构的化合物:The first route includes: performing a first condensation reaction with thiosemicarbazone and p-toluenesulfonic acid to obtain a compound having the structure shown in Formula 2:
具有式2所示结构的化合物与三溴化硼进行第一去甲基化反应,得到KGP94;The compound having the structure shown in Formula 2 undergoes a first demethylation reaction with boron tribromide to obtain KGP94;
所述第二路线包括:3-溴-3'-甲氧基-二苯甲酮与三溴化硼进行第二去甲基化反应,得到3-溴-3'-羟基-二苯甲酮;The second route includes: 3-bromo-3'-methoxy-benzophenone and boron tribromide are subjected to a second demethylation reaction to obtain 3-bromo-3'-hydroxy-benzophenone ;
3-溴-3'-羟基-二苯甲酮与氨基硫脲、对甲苯磺酸进行第二缩合反应,得到KGP94。3-Bromo-3'-hydroxy-benzophenone undergoes a second condensation reaction with thiosemicarbazide and p-toluenesulfonic acid to obtain KGP94.
优选的,所述步骤(1)中,所述3-溴苯甲酰氯与N,O-二甲基羟胺盐酸盐、碳酸钾的摩尔比为1:1.5:2.5。Preferably, in the step (1), the molar ratio of the 3-bromobenzoyl chloride to N,O-dimethylhydroxylamine hydrochloride and potassium carbonate is 1:1.5:2.5.
优选的,所述亲核取代反应的温度为0~30℃,时间为5~7h。Preferably, the temperature of the nucleophilic substitution reaction is 0-30°C and the time is 5-7 hours.
优选的,所述步骤(2)中,所述3-甲氧基苯基溴化镁与具有式1所示结构的酰胺化合物的摩尔比为1.5~2.5:1。Preferably, in the step (2), the molar ratio of the 3-methoxyphenyl magnesium bromide to the amide compound having the structure shown in Formula 1 is 1.5 to 2.5:1.
优选的,所述偶联反应的温度为0~30℃,时间为5~7h。Preferably, the coupling reaction temperature is 0-30°C and the time is 5-7 hours.
优选的,所述第一路线中,3-溴-3'-甲氧基-二苯甲酮与氨基硫脲、对甲苯磺酸的摩尔比为1:(3~3.5):1;Preferably, in the first route, the molar ratio of 3-bromo-3'-methoxy-benzophenone to thiosemicarbazone and p-toluenesulfonic acid is 1:(3~3.5):1;
所述第一缩合反应的温度为75~85℃,时间为20~24h。The temperature of the first condensation reaction is 75-85°C, and the time is 20-24 hours.
优选的,所述第一路线中,具有式2所示结构的化合物与三溴化硼的摩尔比为(0.8~1.2):0.6;Preferably, in the first route, the molar ratio of the compound having the structure shown in Formula 2 to boron tribromide is (0.8~1.2):0.6;
所述第一去甲基化反应的温度为0~30℃,时间为5~7h。The temperature of the first demethylation reaction is 0-30°C, and the time is 5-7 hours.
优选的,所述第二路线中,3-溴-3'-甲氧基-二苯甲酮与三溴化硼的摩尔比为1:0.3~0.5;Preferably, in the second route, the molar ratio of 3-bromo-3'-methoxy-benzophenone and boron tribromide is 1:0.3~0.5;
所述第二去甲基化反应的温度为0~30℃,时间为5~7h。The temperature of the second demethylation reaction is 0-30°C, and the time is 5-7 hours.
优选的,所述第二路线中,3-溴-3'-羟基-二苯甲酮与氨基硫脲、对甲苯磺酸的摩尔比为1:(3~4):(1~1.2);Preferably, in the second route, the molar ratio of 3-bromo-3'-hydroxy-benzophenone to thiosemicarbazone and p-toluenesulfonic acid is 1:(3~4):(1~1.2);
所述第二缩合反应的温度为75~85℃,时间为18~24h。The temperature of the second condensation reaction is 75-85°C, and the time is 18-24 hours.
本发明提供了一种KGP94的制备方法,包括以下步骤:(1)在碳酸钾催化下,3-溴苯甲酰氯与N,O-二甲基羟胺盐酸盐进行亲核取代反应,得到具有式1所示结构的酰胺化合物:(2)3-甲氧基苯基溴化镁与具有式1所示结构的酰胺化合物进行偶联反应,得到3-溴-3'-甲氧基-二苯甲酮;(3)3-溴-3'-甲氧基-二苯甲酮进行第一路线或第二路线,得到KGP94;所述第一路线包括:与氨基硫脲、对甲苯磺酸进行第一缩合反应,得到具有式2所示结构的化合物:具有式2所示结构的化合物与三溴化硼进行第一去甲基化反应,得到KGP94;所述第二路线包括:3-溴-3'-甲氧基-二苯甲酮与三溴化硼进行第二去甲基化反应,得到3-溴-3'-羟基-二苯甲酮;3-溴-3'-羟基-二苯甲酮与氨基硫脲、对甲苯磺酸进行第二缩合反应,得到KGP94。本发明从普通的3-溴苯甲酰氯出发,采用Weinreb酰胺法制备具有式1所示结构的酰胺化合物,再利用格式试剂3-甲氧基苯基溴化镁与具有式1所示结构的酰胺化合物进行偶联,得到3-溴-3'-甲氧基-二苯甲酮。在本发明中,3-溴-3'-甲氧基-二苯甲酮为中间原料,采用先去甲基化后缩合、或者先缩合后去甲基化的方式得到KGP94。本发明提供的方法合成路线短,总收率高,实施例结果表明,本发明提供的方法总收率为80%或89%。The invention provides a preparation method of KGP94, which includes the following steps: (1) Under the catalysis of potassium carbonate, 3-bromobenzoyl chloride and N, O-dimethylhydroxylamine hydrochloride undergo a nucleophilic substitution reaction to obtain The amide compound with the structure shown in Formula 1: (2) 3-methoxyphenyl magnesium bromide and the amide compound with the structure shown in Formula 1 are subjected to a coupling reaction to obtain 3-bromo-3'-methoxy-bis Benzophenone; (3) 3-bromo-3'-methoxy-benzophenone is carried out through the first route or the second route to obtain KGP94; the first route includes: with thiosemicarbazide, p-toluenesulfonic acid The first condensation reaction is performed to obtain a compound with the structure shown in Formula 2: the compound with the structure shown in Formula 2 is subjected to a first demethylation reaction with boron tribromide to obtain KGP94; the second route includes: 3- Bromo-3'-methoxy-benzophenone undergoes a second demethylation reaction with boron tribromide to obtain 3-bromo-3'-hydroxy-benzophenone; 3-bromo-3'-hydroxy -The second condensation reaction of benzophenone with thiosemicarbazide and p-toluenesulfonic acid gives KGP94. The present invention starts from ordinary 3-bromobenzoyl chloride, adopts Weinreb amide method to prepare amide compounds with the structure shown in Formula 1, and then uses Grignard reagent 3-methoxyphenyl magnesium bromide and amide compounds with the structure shown in Formula 1 The amide compound is coupled to obtain 3-bromo-3'-methoxy-benzophenone. In the present invention, 3-bromo-3'-methoxy-benzophenone is used as an intermediate raw material, and KGP94 is obtained by first demethylating and then condensing, or by first condensing and then demethylating. The method provided by the invention has a short synthesis route and high overall yield. The results of the examples show that the overall yield of the method provided by the invention is 80% or 89%.
附图说明Description of drawings
图1为KGP94的合成路线图。Figure 1 shows the synthesis roadmap of KGP94.
具体实施方式Detailed ways
本发明提供了一种KGP94的制备方法,包括以下步骤:The invention provides a preparation method of KGP94, which includes the following steps:
(1)在碳酸钾催化下,3-溴苯甲酰氯与N,O-二甲基羟胺盐酸盐进行亲核取代反应,得到具有式1所示结构的酰胺化合物:(1) Under the catalysis of potassium carbonate, 3-bromobenzoyl chloride and N, O-dimethylhydroxylamine hydrochloride undergo a nucleophilic substitution reaction to obtain an amide compound with the structure shown in Formula 1:
(2)3-甲氧基苯基溴化镁与具有式1所示结构的酰胺化合物进行偶联反应,得到3-溴-3'-甲氧基-二苯甲酮;(2) 3-Methoxyphenylmagnesium bromide is coupled with an amide compound having the structure shown in Formula 1 to obtain 3-bromo-3'-methoxy-benzophenone;
(3)3-溴-3'-甲氧基-二苯甲酮进行第一路线或第二路线,得到KGP94;(3) 3-bromo-3'-methoxy-benzophenone is subjected to the first route or the second route to obtain KGP94;
所述第一路线包括:与氨基硫脲、对甲苯磺酸进行第一缩合反应,得到具有式2所示结构的化合物:The first route includes: performing a first condensation reaction with thiosemicarbazone and p-toluenesulfonic acid to obtain a compound having the structure shown in Formula 2:
具有式2所示结构的化合物与三溴化硼进行第一去甲基化反应,得到KGP94;The compound having the structure shown in Formula 2 undergoes a first demethylation reaction with boron tribromide to obtain KGP94;
所述第二路线包括:3-溴-3'-甲氧基-二苯甲酮与三溴化硼进行第二去甲基化反应,得到3-溴-3'-羟基-二苯甲酮;The second route includes: 3-bromo-3'-methoxy-benzophenone and boron tribromide are subjected to a second demethylation reaction to obtain 3-bromo-3'-hydroxy-benzophenone ;
3-溴-3'-羟基-二苯甲酮与氨基硫脲、对甲苯磺酸进行第二缩合反应,得到KGP94。3-Bromo-3'-hydroxy-benzophenone undergoes a second condensation reaction with thiosemicarbazide and p-toluenesulfonic acid to obtain KGP94.
在本发明中,除特殊说明外,所有反应均在惰性气氛下进行。In the present invention, unless otherwise specified, all reactions are carried out under an inert atmosphere.
本发明在碳酸钾催化下,3-溴苯甲酰氯与N,O-二甲基羟胺盐酸盐进行亲核取代反应,得到具有式1所示结构的酰胺化合物。在本发明中,所述亲核取代反应使用的溶剂优选为氯仿和水,所述氯仿和水的体积比优选为1:1。In the present invention, under the catalysis of potassium carbonate, 3-bromobenzoyl chloride and N, O-dimethylhydroxylamine hydrochloride undergo nucleophilic substitution reaction to obtain an amide compound having the structure shown in Formula 1. In the present invention, the solvent used in the nucleophilic substitution reaction is preferably chloroform and water, and the volume ratio of chloroform and water is preferably 1:1.
在本发明中,所述3-溴苯甲酰氯与N,O-二甲基羟胺盐酸盐、碳酸钾的摩尔比优选为1:(1~2):(2~3),更优选为1:1.5:2.5。在本发明中,所述亲核取代反应的温度优选为0~30℃,时间优选为5~7h,更优选为6h。In the present invention, the molar ratio of the 3-bromobenzoyl chloride to N,O-dimethylhydroxylamine hydrochloride and potassium carbonate is preferably 1:(1~2):(2~3), more preferably 1:1.5:2.5. In the present invention, the temperature of the nucleophilic substitution reaction is preferably 0 to 30°C, and the time is preferably 5 to 7 hours, and more preferably 6 hours.
在本发明中,所述亲核取代反应具体优选为:In the present invention, the nucleophilic substitution reaction is preferably:
将碳酸钾、N,O-二甲基羟胺盐酸盐与溶剂混合,在0℃搅拌下加入3-溴苯甲酰氯,升为至室温,进行亲核取代反应。在本发明中,所述亲核取代反应的反应时间自0℃升温时开始计算。Mix potassium carbonate, N,O-dimethylhydroxylamine hydrochloride and a solvent, add 3-bromobenzoyl chloride while stirring at 0°C, and raise the temperature to room temperature to perform a nucleophilic substitution reaction. In the present invention, the reaction time of the nucleophilic substitution reaction is calculated from the temperature rise of 0°C.
所述亲核取代反应完成后,本发明优选对所得亲核取代反应液进行后处理,所述后处理优选包括以下步骤:After the nucleophilic substitution reaction is completed, the present invention preferably performs post-processing on the obtained nucleophilic substitution reaction solution, and the post-processing preferably includes the following steps:
用氯仿和水稀释亲核取代反应液,分离得到第一有机相;Dilute the nucleophilic substitution reaction solution with chloroform and water, and separate to obtain the first organic phase;
用氯仿对水相进行萃取,得到第二有机相,将第一有机相和第二有机相进行合并,得到合并有机相;Extract the aqueous phase with chloroform to obtain a second organic phase, combine the first organic phase and the second organic phase to obtain a combined organic phase;
对所述合并有机相依次进行碱洗和干燥,得到具有式1所示结构的酰胺化合物。The combined organic phases are sequentially washed with alkali and dried to obtain an amide compound having the structure shown in Formula 1.
在本发明中,所述碱洗使用的碱液优选为浓度为6M的NaOH溶液;在本发明中,所述干燥使用的干燥剂优选为无水Na2SO4。所述干燥后,本发明优选在真空中蒸干固体中的溶剂。In the present invention, the alkali liquid used in the alkali cleaning is preferably a NaOH solution with a concentration of 6M; in the present invention, the desiccant used in the drying is preferably anhydrous Na 2 SO 4 . After said drying, the present invention preferably evaporates the solvent in the solid to dryness in a vacuum.
得到所述具有式1所示结构的酰胺化合物后,3-甲氧基苯基溴化镁与具有式1所示结构的酰胺化合物进行偶联反应,得到3-溴-3'-甲氧基-二苯甲酮。在本发明中,所述偶联反应使用的有机溶剂优选为四氢呋喃、甲苯、二甘醇、2-甲基丙烯醛和环戊基甲醚中的一种或几种。在本发明中,所述3-甲氧基苯基溴化镁与具有式1所示结构的酰胺化合物的摩尔比优选为1.5~2.5:1,更优选为2:1,所述偶联反应的温度优选为0~30℃,时间优选为5~7h,更优为6h。After obtaining the amide compound with the structure shown in Formula 1, 3-methoxyphenyl magnesium bromide and the amide compound with the structure shown in Formula 1 are coupled to obtain 3-bromo-3'-methoxy -Benzophenone. In the present invention, the organic solvent used in the coupling reaction is preferably one or more of tetrahydrofuran, toluene, diethylene glycol, 2-methacrolein and cyclopentyl methyl ether. In the present invention, the molar ratio of the 3-methoxyphenyl magnesium bromide to the amide compound having the structure shown in Formula 1 is preferably 1.5 to 2.5:1, more preferably 2:1, and the coupling reaction The temperature is preferably 0 to 30°C, and the time is preferably 5 to 7 hours, more preferably 6 hours.
在本发明中,所述偶联反应具体优选为:In the present invention, the coupling reaction is preferably:
将3-甲氧基苯基溴化镁与具有式1所示结构的酰胺化合物、有机溶剂混合,自0℃升温至室温,进行偶联反应。在本发明中,所述偶联反应的反应时间自0℃升温时开始计算。Mix 3-methoxyphenylmagnesium bromide with the amide compound having the structure shown in Formula 1 and an organic solvent, and heat the mixture from 0°C to room temperature to perform a coupling reaction. In the present invention, the reaction time of the coupling reaction is calculated from the time when the temperature rises to 0°C.
所述偶联反应完成后,本发明优选对所得偶联反应液进行后处理,在本发明中,所述后处理优选包括以下步骤:After the coupling reaction is completed, the present invention preferably performs post-treatment on the obtained coupling reaction liquid. In the present invention, the post-treatment preferably includes the following steps:
对所述偶联反应液依次进行淬灭、有机溶剂萃取、洗涤和干燥,得到3-溴-3'-甲氧基-二苯甲酮纯品。The coupling reaction solution was quenched, extracted with an organic solvent, washed and dried in order to obtain pure 3-bromo-3'-methoxy-benzophenone.
本发明优选使用冰水进行所述淬灭。在本发明中,所述萃取使用的有机溶剂优选为乙酸乙酯。在本发明中,所述萃取后,本发明优选使用乙酸乙酯对水相再次萃取,合并有机相。在本发明中,所述洗涤用洗涤剂优选为盐水。在本发明中,所述干燥使用的干燥剂优选为无水Na2SO4。In the present invention, it is preferred to use ice water for the quenching. In the present invention, the organic solvent used in the extraction is preferably ethyl acetate. In the present invention, after the extraction, the aqueous phase is preferably extracted again with ethyl acetate and the organic phases are combined. In the present invention, the detergent for washing is preferably brine. In the present invention, the desiccant used for drying is preferably anhydrous Na 2 SO 4 .
得到所述3-溴-3'-甲氧基-二苯甲酮后,第一路线中,3-溴-3'-甲氧基-二苯甲酮与氨基硫脲、对甲苯磺酸进行第一缩合反应,得到具有式2所示结构的化合物。After obtaining the 3-bromo-3'-methoxy-benzophenone, in the first route, 3-bromo-3'-methoxy-benzophenone is carried out with thiosemicarbazone and p-toluenesulfonic acid. The first condensation reaction yields a compound having the structure shown in Formula 2.
在本发明中,所述3-溴-3'-甲氧基-二苯甲酮与氨基硫脲、对甲苯磺酸的摩尔比优选为1:3.5:1。在本发明中,所述第一缩合反应使用的有机溶剂优选为无水乙醇、甲醇和四氢呋喃中的一种或几种。在本发明中,所述第一缩合反应的温度优选为75~85℃,更优选为80℃,时间优选为20~24h,更优选为22h。In the present invention, the molar ratio of the 3-bromo-3'-methoxy-benzophenone to thiosemicarbazone and p-toluenesulfonic acid is preferably 1:3.5:1. In the present invention, the organic solvent used in the first condensation reaction is preferably one or more of absolute ethanol, methanol and tetrahydrofuran. In the present invention, the temperature of the first condensation reaction is preferably 75-85°C, more preferably 80°C, and the time is preferably 20-24h, more preferably 22h.
所述第一缩合反应后,本发明优选对所得第一缩合反应液进行后处理,所述后处理优选包括以下步骤:After the first condensation reaction, the present invention preferably performs post-treatment on the obtained first condensation reaction liquid, and the post-treatment preferably includes the following steps:
蒸发第一缩合反应液中的有机溶剂,用水稀释剩余残留物,依次进行萃取、洗涤、干燥、浓缩和柱层析,得到具有式2所示结构的化合物纯品。The organic solvent in the first condensation reaction solution is evaporated, the remaining residue is diluted with water, and extraction, washing, drying, concentration and column chromatography are performed sequentially to obtain a pure compound having the structure shown in Formula 2.
在本发明中,所述萃取使用的有机溶剂优选为乙酸乙酯。在本发明中,所述萃取后,本发明优选使用乙酸乙酯对水相再次萃取,合并有机相。在本发明中,所述洗涤用洗涤剂优选为NaHCO3溶液,所述干燥使用的干燥剂优选为无水Na2SO4。本发明对所述浓缩的方式没有特殊的要求,使用本领域技术人员熟知的浓缩方式即可。In the present invention, the organic solvent used in the extraction is preferably ethyl acetate. In the present invention, after the extraction, the aqueous phase is preferably extracted again with ethyl acetate and the organic phases are combined. In the present invention, the detergent for washing is preferably a NaHCO 3 solution, and the desiccant used for drying is preferably anhydrous Na 2 SO 4 . The present invention has no special requirements for the concentration method, and any concentration method well known to those skilled in the art can be used.
在本发明中,所述柱层析使用的流动相优选为石油醚:乙酸乙酯,所述石油醚:乙酸乙酯的体积比优选为20:3.5~5.0。In the present invention, the mobile phase used in the column chromatography is preferably petroleum ether:ethyl acetate, and the volume ratio of petroleum ether:ethyl acetate is preferably 20:3.5-5.0.
得到所述具有式2所示结构的化合物后,具有式2所示结构的化合物与三溴化硼进行第一去甲基化反应,得到KGP94。在本发明中,所述第一去甲基化反应使用的有机溶剂优选为二氯甲烷和/或氯仿。在本发明中,所述具有式2所示结构的化合物与三溴化硼的摩尔比优选为0.8~1.2:0.6,更优选为1:0.6。在本发明中,所述第一去甲基化反应的温度优选为0~30℃,时间优选为5~7h,更优选为6h。After obtaining the compound having the structure represented by Formula 2, the compound having the structure represented by Formula 2 is subjected to a first demethylation reaction with boron tribromide to obtain KGP94. In the present invention, the organic solvent used in the first demethylation reaction is preferably dichloromethane and/or chloroform. In the present invention, the molar ratio of the compound having the structure shown in Formula 2 to boron tribromide is preferably 0.8-1.2:0.6, more preferably 1:0.6. In the present invention, the temperature of the first demethylation reaction is preferably 0 to 30°C, and the time is preferably 5 to 7 hours, and more preferably 6 hours.
在本发明中,所述第一去甲基反应具体优选为:In the present invention, the first demethylation reaction is preferably:
将具有式2所示结构的化合物、有机溶剂在0℃下混合,加入三溴化硼,升温至室温,进行第一去甲基化反应。在本发明中,所述第一去甲基化反应的反应时间自0℃升温时开始计算。The compound having the structure shown in Formula 2 and the organic solvent are mixed at 0°C, boron tribromide is added, the temperature is raised to room temperature, and the first demethylation reaction is performed. In the present invention, the reaction time of the first demethylation reaction is calculated from the time when the temperature is raised to 0°C.
所述第一去甲基化反应后,本发明优选对所得第一去甲基化反应液进行后处理,所述后处理优选包括以下步骤:After the first demethylation reaction, the present invention preferably performs post-processing on the obtained first demethylation reaction liquid, and the post-processing preferably includes the following steps:
对所述第一去甲基化反应液依次进行淬灭、有机溶剂萃取、洗涤、干燥、浓缩和柱层析,得到3-溴-3'-甲氧基-二苯甲酮纯品。The first demethylation reaction solution is sequentially quenched, extracted with an organic solvent, washed, dried, concentrated and column chromatographed to obtain pure 3-bromo-3'-methoxy-benzophenone.
本发明优选使用冰水进行所述淬灭。在本发明中,所述萃取使用的有机溶剂优选为二氯甲烷。所述萃取后,本发明优选使用二氯甲烷对所得水相进行再次萃取,合并有机相。在本发明中,所述洗涤用洗涤剂优选为NaHCO3溶液和盐水溶液,所述干燥使用的干燥剂优选为无水Na2SO4。本发明对所述浓缩的方式没有特殊的要求,使用本领域技术人员熟知的浓缩方式即可。In the present invention, it is preferred to use ice water for the quenching. In the present invention, the organic solvent used in the extraction is preferably methylene chloride. After the extraction, the present invention preferably uses dichloromethane to extract the obtained aqueous phase again, and combine the organic phases. In the present invention, the detergent for washing is preferably NaHCO 3 solution and brine solution, and the desiccant used for drying is preferably anhydrous Na 2 SO 4 . The present invention has no special requirements for the concentration method, and any concentration method well known to those skilled in the art can be used.
在本发明中,所述柱层析使用的流动相优选为石油醚和乙酸乙酯,所述石油醚和乙酸乙酯的体积比优选为20:5~6。In the present invention, the mobile phase used in the column chromatography is preferably petroleum ether and ethyl acetate, and the volume ratio of the petroleum ether and ethyl acetate is preferably 20:5-6.
得到所述3-溴-3'-甲氧基-二苯甲酮后,第二路线中,3-溴-3'-甲氧基-二苯甲酮与三溴化硼进行第二去甲基化反应,得到3-溴-3'-羟基-二苯甲酮;After obtaining the 3-bromo-3'-methoxy-benzophenone, in the second route, 3-bromo-3'-methoxy-benzophenone and boron tribromide undergo the second demethylation Kylation reaction gives 3-bromo-3'-hydroxy-benzophenone;
3-溴-3'-羟基-二苯甲酮与氨基硫脲、对甲苯磺酸进行第二缩合反应,得到KGP94。3-Bromo-3'-hydroxy-benzophenone undergoes a second condensation reaction with thiosemicarbazide and p-toluenesulfonic acid to obtain KGP94.
在本发明中,所述第二去甲基化使用的有机溶剂优选为二氯甲烷和/或氯仿。在本发明中,所述3-溴-3'-甲氧基-二苯甲酮与三溴化硼的摩尔比优选为1:0.3~0.5,更优选为1:0.4。在本发明中,所述第二去甲基化反应的温度优选为0~30℃,时间优选为5~7h,更优选为6h。In the present invention, the organic solvent used in the second demethylation is preferably dichloromethane and/or chloroform. In the present invention, the molar ratio of 3-bromo-3'-methoxy-benzophenone and boron tribromide is preferably 1:0.3-0.5, more preferably 1:0.4. In the present invention, the temperature of the second demethylation reaction is preferably 0 to 30°C, and the time is preferably 5 to 7 hours, and more preferably 6 hours.
在本发明中,所述第二去甲基反应具体优选为:In the present invention, the second demethylation reaction is preferably:
3-溴-3'-甲氧基-二苯甲酮、有机溶剂在0℃下混合,加入三溴化硼,升温至室温,进行第一去甲基化反应。在本发明中,所述第二去甲基化反应的反应时间自0℃升温时开始计算。Mix 3-bromo-3'-methoxy-benzophenone and an organic solvent at 0°C, add boron tribromide, raise the temperature to room temperature, and perform the first demethylation reaction. In the present invention, the reaction time of the second demethylation reaction is calculated from the temperature rise of 0°C.
所述第二去甲基化反应后,本发明优选对所得第二去甲基化反应液进行后处理,所述后处理的方式优选与第一去甲基化反应液的后处理方式相同,在此不再赘述。After the second demethylation reaction, the present invention preferably performs post-processing on the obtained second demethylation reaction liquid. The post-processing method is preferably the same as the post-processing method of the first demethylation reaction liquid. I won’t go into details here.
得到所述3-溴-3'-羟基-二苯甲酮后,3-溴-3'-羟基-二苯甲酮与氨基硫脲、对甲苯磺酸进行第二缩合反应,得到KGP94。在本发明中,所述第二缩合反应使用的有机溶剂优选为无水乙醇。在本发明中,所述3-溴-3'-羟基-二苯甲酮与氨基硫脲、对甲苯磺酸的摩尔比优选为1:(3~4):(1~1.2),更优选为1:3.5:1。在本发明中,所述第二缩合反应的温度优选为75~85℃,更优选为80℃,时间优选为18~24h,更优选为20h。After obtaining the 3-bromo-3'-hydroxy-benzophenone, 3-bromo-3'-hydroxy-benzophenone is subjected to a second condensation reaction with thiosemicarbazide and p-toluenesulfonic acid to obtain KGP94. In the present invention, the organic solvent used in the second condensation reaction is preferably absolute ethanol. In the present invention, the molar ratio of the 3-bromo-3'-hydroxy-benzophenone to thiosemicarbazone and p-toluenesulfonic acid is preferably 1:(3~4):(1~1.2), more preferably is 1:3.5:1. In the present invention, the temperature of the second condensation reaction is preferably 75-85°C, more preferably 80°C, and the time is preferably 18-24h, more preferably 20h.
在本发明中,所述第二缩合反应后,本发明优选对所得第二缩合反应液进行后处理,所述后处理的方式优选与第一缩合反应液的后处理方式相同,在此不再赘述。In the present invention, after the second condensation reaction, the present invention preferably performs post-treatment on the obtained second condensation reaction liquid. The post-treatment method is preferably the same as the post-treatment method of the first condensation reaction liquid, which will not be repeated here. Repeat.
在本发明中,所述KGP94的合成路线图如图1所示。In the present invention, the synthetic route diagram of KGP94 is shown in Figure 1.
下面结合实施例对本发明提供的KGP94的制备方法进行详细的说明,但是不能把它们理解为对本发明保护范围的限定。The preparation method of KGP94 provided by the present invention will be described in detail below with reference to the examples, but they should not be understood as limiting the protection scope of the present invention.
以下实施例中,除特殊说明外,所有反应均在惰性气氛下进行。In the following examples, unless otherwise stated, all reactions were carried out under an inert atmosphere.
核磁共振氢谱(1H-NMR)为ruker Avance 400光谱仪在400MHz处测定,核磁共振碳谱(13C-NMR)在100MHz处测定。残留丙酮(δ2.05;206.6,29.9),氯仿(δ7.24;77.2)和二甲亚砜(δ2.50;39.5)作为氢谱、碳谱的溶剂峰内部参考,四甲基硅烷(TMS)作为内标,峰形表示:s(单峰)、d(双峰)、t(三峰)、q(四峰)、dd(双二重峰)、ddd(三二重峰)、m(双峰)、brs(宽单峰)。耦合常数表示为J(单位:Hz),化学位移表示为δ(单位:ppm)。高分辨质谱为安捷伦6540q-TOF(电喷雾电离,ESI-TOF)质谱仪所检测。柱层析使用200~300目硅胶。薄层层析使用HSGF254硅胶板,紫外光(254nm)或高锰酸钾显色。The hydrogen nuclear magnetic resonance spectrum (1H-NMR) was measured at 400MHz with a ruker Avance 400 spectrometer, and the carbon nuclear magnetic resonance spectrum (13C-NMR) was measured at 100MHz. Residual acetone (δ2.05; 206.6, 29.9), chloroform (δ7.24; 77.2) and dimethyl sulfoxide (δ2.50; 39.5) are used as internal references for the solvent peaks of hydrogen and carbon spectra, and tetramethylsilane (TMS ) as the internal standard, the peak shape indicates: s (single peak), d (double peak), t (triple peak), q (quadruple peak), dd (double doublet), ddd (triple doublet), m ( double peak), brs (broad single peak). The coupling constant is expressed as J (unit: Hz), and the chemical shift is expressed as δ (unit: ppm). High-resolution mass spectrometry was detected by Agilent 6540q-TOF (electrospray ionization, ESI-TOF) mass spectrometer. Column chromatography uses 200 to 300 mesh silica gel. Thin layer chromatography uses HSGF254 silica gel plate, and UV light (254nm) or potassium permanganate is used for color development.
实施例1Example 1
(1)制备具有式1所示结构的酰胺化合物(1) Preparation of amide compounds having the structure shown in Formula 1
将N,O-二甲基羟胺盐酸盐(2.053g,21.051mmol,1.5eq.,98%)和碳酸钾(4.849g,35.086mmol,2.5eq.,99%)溶于氯仿(15.0mL)和水(15.0mL)的混合溶剂中,在0℃搅拌下逐滴加入3-溴苯甲酰氯3(3.080g,14.034mmol,1.0eq.,97%),10分钟后逐渐升温至室温,继续搅拌反应。6小时后用氯仿和水稀释反应液,分离有机相,用氯仿进一步萃取水相,合并有机相,用6M NaOH溶液洗涤,分离有机相,用无水Na2SO4干燥。在真空中蒸干溶剂后得到就是式1所示结构的Weinreb酰胺化合物(3.392g,收率99%),性状为无色液体。Dissolve N,O-dimethylhydroxylamine hydrochloride (2.053g, 21.051mmol, 1.5eq., 98%) and potassium carbonate (4.849g, 35.086mmol, 2.5eq., 99%) in chloroform (15.0mL) and water (15.0 mL), add 3-bromobenzoyl chloride 3 (3.080g, 14.034mmol, 1.0eq., 97%) dropwise with stirring at 0°C, and gradually warm to room temperature after 10 minutes, continue Stir the reaction. After 6 hours, dilute the reaction solution with chloroform and water, separate the organic phase, further extract the aqueous phase with chloroform, combine the organic phases, wash with 6M NaOH solution, separate the organic phase, and dry over anhydrous Na 2 SO 4 . After the solvent was evaporated to dryness in a vacuum, the Weinreb amide compound (3.392g, yield 99%) with the structure shown in Formula 1 was obtained as a colorless liquid.
1H-NMR(400MHz,CDCl3)δ7.74(s,1H,Ar-H),7.54-7.49(m,2H,2xAr-H),7.20(t,J=7.8Hz,1H,Ar-H),3.47(s,3H,OCH3),3.27(s,3H,NCH3);13C-NMR(100MHz,CDCl3)δ168.1(C=O),135.9(C),133.5(CH),131.2(CH),129.6(CH),126.7(CH),122.0(C),61.2(OCH3),33.5(NCH3);HRMS(ESI)calcd.for C9H10BrNO2[M+H]+243.9968,found 243.9969. 1 H-NMR (400MHz, CDCl 3 ) δ7.74 (s, 1H, Ar-H), 7.54-7.49 (m, 2H, 2xAr-H), 7.20 (t, J=7.8Hz, 1H, Ar-H ),3.47(s,3H,OCH 3 ),3.27(s,3H,NCH 3 ); 13 C-NMR(100MHz,CDCl 3 )δ168.1(C=O),135.9(C),133.5(CH) ,131.2(CH),129.6(CH),126.7(CH),122.0(C),61.2(OCH 3 ),33.5(NCH 3 ); HRMS(ESI)calcd.for C 9 H 10 BrNO 2 [M+H ] + 243.9968,found 243.9969.
反应过程如式A所示:The reaction process is shown in formula A:
(2)制备3-溴-3'-甲氧基-二苯甲酮(2) Preparation of 3-bromo-3'-methoxy-benzophenone
0℃氩气保护下,将3-甲氧基苯基溴化镁(1.0M,28mL,27.793mmol,2.0eq.,98%四氢呋喃溶液)加入到搅拌脱气溶解了具有式1所示结构的酰胺化合物(3.392g,13.896mmol,1.0eq.)的干燥的四氢呋喃溶液中,0℃搅拌30分钟后逐渐升至室温继续搅拌反应。4小时后用冰水淬火反应,乙酸乙酯萃取,分离有机相,水相用乙酸乙酯进一步萃取,合并有机相,然后用盐水洗涤,无水Na2SO4干燥,浓缩,柱层析(石油醚:乙酸乙酯,梯度20:0.5至20:1.5)纯化,得到淡黄色产物,为3-溴-3'-甲氧基-二苯甲酮(3.860g,产率95%)。Under argon protection at 0°C, 3-methoxyphenylmagnesium bromide (1.0M, 28mL, 27.793mmol, 2.0eq., 98% tetrahydrofuran solution) was added to the mixture, stirred, degassed and dissolved. The solution of the amide compound (3.392g, 13.896mmol, 1.0eq.) in dry tetrahydrofuran was stirred at 0°C for 30 minutes and then gradually raised to room temperature to continue stirring the reaction. After 4 hours, the reaction was quenched with ice water, extracted with ethyl acetate, and the organic phase was separated. The aqueous phase was further extracted with ethyl acetate, the organic phases were combined, then washed with brine, dried over anhydrous Na 2 SO 4 , concentrated, and column chromatographed ( Petroleum ether: ethyl acetate, gradient 20:0.5 to 20:1.5) was purified to obtain a light yellow product, which was 3-bromo-3'-methoxy-benzophenone (3.860g, yield 95%).
1H-NMR(400MHz,CDCl3)δ7.85(s,1H,Ar-H),7.64-7.62(dd,J=6.2,1.5Hz,2H,2xAr-H),7.33-7.22(m,4H,4xAr-H),7.08-7.06(dd,J=6.0,1.8Hz,1H,Ar-H),3.78(s,3H,OCH3);13C-NMR(100MHz,CDCl3)δ194.9(C=O),159.6(C),139.5(C),138.1(C),135.2(CH),132.7(CH),129.8(CH),129.4(CH),128.5(CH),122.8(C),122.5(CH),119.3(CH),114.2(CH),55.5(OCH3);HRMS(ESI)calcd.for C14H11BrO2[M+H]+291.0015,found 291.0017. 1 H-NMR (400MHz, CDCl 3 ) δ7.85 (s, 1H, Ar-H), 7.64-7.62 (dd, J = 6.2, 1.5Hz, 2H, 2xAr-H), 7.33-7.22 (m, 4H , 4xAr-H), 7.08-7.06 (dd, J=6.0, 1.8Hz, 1H, Ar-H), 3.78 (s, 3H, OCH 3 ); 13 C-NMR (100MHz, CDCl 3 ) δ 194.9 ( C=O),159.6(C),139.5(C),138.1(C),135.2(CH),132.7(CH),129.8(CH),129.4(CH),128.5(CH),122.8(C), 122.5(CH),119.3(CH),114.2(CH),55.5(OCH 3 ); HRMS(ESI)calcd.for C 14 H 11 BrO 2 [M+H] + 291.0015, found 291.0017.
反应过程如式B所示:The reaction process is shown in formula B:
(3)具有式2所示结构的化合物的制备(3) Preparation of compounds having the structure shown in Formula 2
将3-溴-3'-甲氧基-二苯甲酮(1.000g,3.434mmol,1.0eq.)、氨基硫脲(1.095g,12.021mmol,3.5eq.,99%)和对甲苯磺酸一水合物(0.653,3.434mmol,1.0eq.,98%)溶于无水乙醇(45mL)中,80℃加热回流反应22小时。反应完成后,在真空中蒸发乙醇。然后用水稀释残渣,用乙酸乙酯萃取,分离有机相,用乙酸乙酯进一步萃取水相,合并有机相,NaHCO3溶液洗涤,无水Na2SO4干燥,浓缩,柱层析(石油醚:乙酸乙酯,梯度,石油醚:乙酸乙酯,梯度,20:3.5至20:5.0)纯化,得到白色结晶状产物(1.239g,产率99%)。3-Bromo-3'-methoxy-benzophenone (1.000g, 3.434mmol, 1.0eq.), thiosemicarbazide (1.095g, 12.021mmol, 3.5eq., 99%) and p-toluenesulfonic acid Monohydrate (0.653, 3.434 mmol, 1.0 eq., 98%) was dissolved in absolute ethanol (45 mL), and the reaction was heated to reflux at 80°C for 22 hours. After the reaction was completed, the ethanol was evaporated in vacuo. Then the residue was diluted with water, extracted with ethyl acetate, the organic phase was separated, the aqueous phase was further extracted with ethyl acetate, the organic phases were combined, washed with NaHCO 3 solution, dried over anhydrous Na 2 SO 4 , concentrated, and column chromatography (petroleum ether: Purification (ethyl acetate, gradient, petroleum ether:ethyl acetate, gradient, 20:3.5 to 20:5.0) gave the product as white crystals (1.239 g, yield 99%).
1H-NMR(400MHz,(CD3)2CO)δ8.57(brs,1H,NH),8.23(brs,1H,NH),7.97(s,1H,Ar-H),7.78(brs,1H,NH),7.63-7.56(3H,m,Ar-H),7.31(t,J=7.9Hz,1H,Ar-H),7.19(dd,J=8.4,1.9Hz,1H,Ar-H),6.96-6.94(m,2H,Ar-H)3.88(s,3H,OCH3);13C-NMR(100MHz,(CD3)2CO)δ180.4(C=S),161.7(C),148.3(C=N),139.8(C),133.3(CH),133.1(C),132.2(CH),131.1(CH),130.5(CH),127.6(CH),123.1(C),121.0(CH),116.7(CH),114.5(CH),55.9(OCH3);HRMS(ESI)calcd.for C15H14BrN3OS[M+H]+364.0114,found 364.0119. 1 H-NMR (400MHz, (CD 3 ) 2 CO) δ8.57(brs,1H,NH),8.23(brs,1H,NH),7.97(s,1H,Ar-H),7.78(brs,1H ,NH),7.63-7.56(3H,m,Ar-H),7.31(t,J=7.9Hz,1H,Ar-H),7.19(dd,J=8.4,1.9Hz,1H,Ar-H) ,6.96-6.94(m,2H,Ar-H)3.88(s,3H,OCH 3 ); 13 C-NMR(100MHz,(CD 3 ) 2 CO)δ180.4(C=S),161.7(C) ,148.3(C=N),139.8(C),133.3(CH),133.1(C),132.2(CH),131.1(CH),130.5(CH),127.6(CH),123.1(C),121.0( CH),116.7(CH),114.5(CH),55.9(OCH 3 ); HRMS(ESI)calcd.for C 15 H 14 BrN 3 OS[M+H] + 364.0114,found 364.0119.
反应过程如式C所示:The reaction process is shown in formula C:
(4)KGP94的制备(4) Preparation of KGP94
将具有式2所示结构的化合物(0.500g,1.372mmol,1.0eq.)溶解于无水二氯甲烷(15mL)中并冷却至0℃,然后逐滴加入三溴化硼(1.0M,0.8mL,0.6eq.,99.9%二氯甲烷溶液),逐渐恢复至室温继续搅拌反应。6小时后用冰水淬火反应液,二氯甲烷萃取分离有机相,用二氯甲烷进一步萃取水相,合并有机相,用NaHCO3溶液和盐水溶液洗涤,无水Na2SO4干燥,浓缩,柱层析(石油醚:乙酸乙酯,梯度20:5.0至20:6.0)纯化,得到白色固体产物,为KGP94(0.461g,产率96%),E:Z=4.5:1。The compound with the structure shown in Formula 2 (0.500g, 1.372mmol, 1.0eq.) was dissolved in anhydrous dichloromethane (15mL) and cooled to 0°C, and then boron tribromide (1.0M, 0.8 mL, 0.6eq., 99.9% methylene chloride solution), gradually returned to room temperature and continued to stir the reaction. After 6 hours, the reaction solution was quenched with ice water, the organic phase was separated by extraction with dichloromethane, the aqueous phase was further extracted with dichloromethane, the organic phases were combined, washed with NaHCO 3 solution and brine solution, dried over anhydrous Na 2 SO 4 and concentrated. Purification by column chromatography (petroleum ether: ethyl acetate, gradient 20:5.0 to 20:6.0) gave a white solid product, which was KGP94 (0.461g, yield 96%), E:Z=4.5:1.
1H-NMR(400MHz,DMSO-d6)δ9.98(s,1H,OH),8.68(brs,1H,NH),8.55(brs,1H,NH),8.42(brs,1H,NH),8.05(s,1H,Ar-H),7.57(ddd,J=7.7,1.95,1.0Hz,1H,Ar-H),7.78-7.44(m,2H,2x Ar-H),7.31(t,J=7.9Hz,1H,Ar-H),7.02(dd,J=6.5,1.7Hz,1H,Ar-H),6.73-6.71(m,1H,Ar-H),6.66-6.65(m,1H,Ar-H).13C-NMR(100MHz,DMSO-d6,)δ177.8(C=S),158.5(C),147.3(C=N),138.5(C),132.3(CH),131.6(C),131.3(CH),130.4(CH),129.3(CH),126.9(CH),122.1(C),118.3(CH),117.2(CH),114.5(CH);HRMS(ESI)calcd.forC14H12BrN3OS[M+H]+349.9957,found 349.9964. 1 H-NMR (400MHz, DMSO-d 6 ) δ9.98(s,1H,OH),8.68(brs,1H,NH),8.55(brs,1H,NH),8.42(brs,1H,NH), 8.05(s,1H,Ar-H),7.57(ddd,J=7.7,1.95,1.0Hz,1H,Ar-H),7.78-7.44(m,2H,2x Ar-H),7.31(t,J =7.9Hz,1H,Ar-H),7.02(dd,J=6.5,1.7Hz,1H,Ar-H),6.73-6.71(m,1H,Ar-H),6.66-6.65(m,1H, Ar-H). 13 C-NMR (100MHz, DMSO-d 6 ,) δ177.8(C=S), 158.5(C), 147.3(C=N), 138.5(C), 132.3(CH), 131.6 (C),131.3(CH),130.4(CH),129.3(CH),126.9(CH),122.1(C),118.3(CH),117.2(CH),114.5(CH); HRMS(ESI)calcd. forC 14 H 12 BrN 3 OS[M+H]+349.9957,found 349.9964.
反应过程如式D所示:The reaction process is shown in formula D:
KGP94的亚胺(C=N)双键在溶液中主要为E构型,该构型通过联合ROESY(Rotating-Frame Overhauser Spectroscopy)、HMBC(Heteronuclear Multiple BondCorrelation)和COSY(Correlation Spectroscopy)谱图来确定。在ROESY谱中,NH(δ8.42)与C-H(δ6.73)和C-H(δ6.66)显著相关;在HMB谱图中,NH(δ8.42)与C=S(177.8)强相关(2J(强)),与C=N(147.3)弱相关(3J(弱));在COSY谱图中,可分别找到NHaHb(δ8.68,8.55)两个质子。KGP94及其类似物化合物2的E构型和Z构型能快速相互转化,不能被单独分离,E:Z的比例是通过整合纯化混合物的1H-NMR光谱中两个异构质子的特征信号来确定。The imine (C=N) double bond of KGP94 is mainly in the E configuration in solution. This configuration is determined by combining ROESY (Rotating-Frame Overhauser Spectroscopy), HMBC (Heteronuclear Multiple Bond Correlation) and COSY (Correlation Spectroscopy) spectra. . In the ROESY spectrum, NH (δ8.42) is significantly correlated with C-H (δ6.73) and C-H (δ6.66); in the HMB spectrum, NH (δ8.42) is strongly correlated with C=S (177.8) ( 2J (strong)), weakly correlated with C=N (147.3) (3J (weak)); in the COSY spectrum, two protons of NHaHb (δ8.68, 8.55) can be found respectively. The E and Z configurations of KGP94 and its analog compound 2 can quickly convert into each other and cannot be separated separately. The E:Z ratio is determined by integrating the characteristic signals of two isomeric protons in the 1H-NMR spectrum of the purified mixture. Sure.
实施例2Example 2
按照实施例1的方式制备具有式1所示结构的酰胺化合物和3-溴-3'-甲氧基-二苯甲酮。The amide compound having the structure shown in Formula 1 and 3-bromo-3'-methoxy-benzophenone were prepared in the same manner as in Example 1.
(1)3-溴-3'-羟基-二苯甲酮的制备(1) Preparation of 3-bromo-3'-hydroxy-benzophenone
将3-溴-3'-甲氧基-二苯甲酮(2.860g,9.823mmol,1.0eq.)溶于无水二氯甲烷(40mL)溶液中,0℃下,加入三溴化硼(1.0M,4.2mL,0.4eq.,99.9%二氯甲烷溶液),室温下搅拌反应6小时后,将混合物缓慢转移到冰水中,然后用二氯甲烷萃取,分离有机相,二氯甲烷进一步萃取水相,合并有机相,用NaHCO3溶液和盐水溶液洗涤,无水Na2SO4干燥,浓缩,柱层析(石油醚:乙酸乙酯,梯度20:2.0至20:4.0)纯化,得到白色固体产物,即3-溴-3'-羟基-二苯甲酮(2.391g,产率88%)。Dissolve 3-bromo-3'-methoxy-benzophenone (2.860g, 9.823mmol, 1.0eq.) in anhydrous dichloromethane (40mL) solution, and add boron tribromide ( 1.0M, 4.2mL, 0.4eq., 99.9% dichloromethane solution), stir the reaction at room temperature for 6 hours, slowly transfer the mixture to ice water, and then extract with dichloromethane, separate the organic phase, and further extract with dichloromethane The aqueous phase was combined with the organic phase, washed with NaHCO 3 solution and brine solution, dried over anhydrous Na 2 SO 4 , concentrated, and purified by column chromatography (petroleum ether: ethyl acetate, gradient 20:2.0 to 20:4.0) to obtain white The solid product was 3-bromo-3'-hydroxy-benzophenone (2.391 g, yield 88%).
1H-NMR(400MHz,CDCl3)δ7.84(brs,1H,Ar-H),7.61(dd,J=6.7,1.1Hz,2H,2x Ar-H),7.26(t,J=7.9Hz,3H,3x Ar-H),7.20(d,J=7.7Hz,1H,Ar-H),7.05(dd,J=7.9,1.7Hz,1H,Ar-H),6.43(brs,1H,OH),13C-NMR(100MHz,CDCl3)δ194.7(C=O),155.1(C),138.1(C),137.0(C),134.5(CH),131.8(CH),128.8(CH),128.7(CH),127.6(CH),121.8(CH),121.5(C),119.5(CH),115.4(CH);HRMS(ESI)calcd.for C13H9BrO2[M+H]+276.9859,found276.9860. 1 H-NMR (400MHz, CDCl 3 ) δ7.84 (brs, 1H, Ar-H), 7.61 (dd, J=6.7, 1.1Hz, 2H, 2x Ar-H), 7.26 (t, J=7.9Hz ,3H,3x Ar-H),7.20(d,J=7.7Hz,1H,Ar-H),7.05(dd,J=7.9,1.7Hz,1H,Ar-H),6.43(brs,1H,OH ), 13 C-NMR (100MHz, CDCl 3 ) δ194.7(C=O),155.1(C),138.1(C),137.0(C),134.5(CH),131.8(CH),128.8(CH) ,128.7(CH),127.6(CH),121.8(CH),121.5(C),119.5(CH),115.4(CH); HRMS(ESI)calcd.for C 13 H 9 BrO 2 [M+H] + 276.9859,found276.9860.
反应过程如式E所示:The reaction process is shown in Formula E:
(2)KGP94的制备(2) Preparation of KGP94
将3-溴-3'-羟基-二苯甲酮(2.391g,8.628mmol,1.0eq.)、氨基硫脲(2.751g,30.198mmol,3.5eq.,99%)和对甲苯磺酸一水合物(1.6411g,8.628mmol,1.0eq.,98%)溶解于无水乙醇(60.0mL)中,超声处理10分钟后,80℃氩气保护下回流反应20小时。反应完成后,减压除去乙醇,残液用到乙酸乙酯提取,并进一步萃取水相,合并有机相,用NaHCO3溶液洗涤,无水Na2SO4干燥,浓缩,柱层析(石油醚:乙酸乙酯,梯度,20:4.0至20:6.0)纯化,得到白色固体产物(2.930g,产率97%),E:Z=4.5:1。3-Bromo-3'-hydroxy-benzophenone (2.391g, 8.628mmol, 1.0eq.), thiosemicarbazide (2.751g, 30.198mmol, 3.5eq., 99%) and p-toluenesulfonic acid monohydrate The compound (1.6411g, 8.628mmol, 1.0eq., 98%) was dissolved in absolute ethanol (60.0mL). After ultrasonic treatment for 10 minutes, the reaction was refluxed at 80°C under argon protection for 20 hours. After the reaction was completed, the ethanol was removed under reduced pressure, and the residual liquid was extracted with ethyl acetate, and the aqueous phase was further extracted, the organic phases were combined, washed with NaHCO 3 solution, dried over anhydrous Na 2 SO 4 , concentrated, and column chromatographed (petroleum ether : Ethyl acetate, gradient, 20:4.0 to 20:6.0) was purified to obtain a white solid product (2.930g, yield 97%), E:Z=4.5:1.
1H-NMR(400MHz,(CD3)2CO)δ8.93(brs,1H,OH),8.61(brs,1H,NH),8.24(brs,1H,NH),7.97(s,1H,Ar-H),7.78(brs,1H,NH),7.58-7.50(3H,m,Ar-H),7.31(t,J=7.7Hz,1H,Ar-H),7.10(d,J=7.5Hz,1H,Ar-H),6.85-6.83(m,2H,Ar-H);13C-NMR(100MHz,(CD3)2CO)δ180.4(C=S),159.5(C),148.5(C=N),139.9(C),133.3(CH),133.1(C),132.3(CH),131.1(CH),130.6(CH),127.7(CH),123.1(C),120.0(CH),118.3(CH),115.8(CH);HRMS(ESI)calcd.for C14H12BrN3OS[M+H]+349.9957,found 349.9963. 1 H-NMR (400MHz, (CD 3 ) 2 CO) δ8.93(brs,1H,OH),8.61(brs,1H,NH),8.24(brs,1H,NH),7.97(s,1H,Ar -H),7.78(brs,1H,NH),7.58-7.50(3H,m,Ar-H),7.31(t,J=7.7Hz,1H,Ar-H),7.10(d,J=7.5Hz ,1H,Ar-H),6.85-6.83(m,2H,Ar-H); 13 C-NMR(100MHz,(CD 3 ) 2 CO)δ180.4(C=S),159.5(C),148.5 (C=N),139.9(C),133.3(CH),133.1(C),132.3(CH),131.1(CH),130.6(CH),127.7(CH),123.1(C),120.0(CH) ,118.3(CH),115.8(CH);HRMS(ESI)calcd.for C 14 H 12 BrN 3 OS[M+H] + 349.9957,found 349.9963.
反应过程如式F所示:The reaction process is shown in Formula F:
以上所述仅是本发明的优选实施方式,应当指出,对于本技术领域的普通技术人员来说,在不脱离本发明原理的前提下,还可以做出若干改进和润饰,这些改进和润饰也应视为本发明的保护范围。The above are only preferred embodiments of the present invention. It should be noted that those skilled in the art can make several improvements and modifications without departing from the principles of the present invention. These improvements and modifications can also be made. should be regarded as the protection scope of the present invention.
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110879143.4A CN115701422B (en) | 2021-08-02 | 2021-08-02 | Preparation method of KGP94 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110879143.4A CN115701422B (en) | 2021-08-02 | 2021-08-02 | Preparation method of KGP94 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN115701422A CN115701422A (en) | 2023-02-10 |
CN115701422B true CN115701422B (en) | 2024-02-09 |
Family
ID=85142336
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110879143.4A Active CN115701422B (en) | 2021-08-02 | 2021-08-02 | Preparation method of KGP94 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115701422B (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003294750A1 (en) * | 2002-12-13 | 2004-07-09 | Basf Aktiengesellschaft | Method for the production of benzophenones |
WO2017030983A1 (en) * | 2015-08-14 | 2017-02-23 | Mateon Therapeutics, Inc. | Compositions and methods for inhibition of cathepsins |
-
2021
- 2021-08-02 CN CN202110879143.4A patent/CN115701422B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003294750A1 (en) * | 2002-12-13 | 2004-07-09 | Basf Aktiengesellschaft | Method for the production of benzophenones |
WO2017030983A1 (en) * | 2015-08-14 | 2017-02-23 | Mateon Therapeutics, Inc. | Compositions and methods for inhibition of cathepsins |
Non-Patent Citations (2)
Title |
---|
Gan, Yonghong等. Nonsteroidal Benzophenone-Containing Analogs of Cholestero.2006,第71卷(第16期),P5864-5869. * |
Synthesis of bromo-methoxyl benzophenone imidazole compounds and their protective activities against hydrogen peroxide induced injury in EA. hy 926 cells;Song, Ting等;Yingyong Huaxue;第34卷(第7期);P783-788 * |
Also Published As
Publication number | Publication date |
---|---|
CN115701422A (en) | 2023-02-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN115701422B (en) | Preparation method of KGP94 | |
US9034439B2 (en) | Synthesis and applications of soluble pentacene precursors and related compounds | |
CN102391086B (en) | A kind of method for preparing 3-methylenenopinone | |
CN114507237B (en) | Azapolycyclic fused ring compound based on acenaphthopyrazinooxaline and synthetic method | |
Akabori et al. | Syntheses of polyoxathia (n) ferrocenophanes and its extraction ability with metal cations. | |
CN115650951A (en) | Diaryl ethylene organic photochromic material and preparation method thereof | |
CN115073479A (en) | Naphthodipyrrole constructed expanded porphyrin with near-infrared absorption property, and preparation method and application thereof | |
de la Torre et al. | An efficient cyclization of lapachol to new benzo [h] chromene hybrid compounds: A stepwise vs. one-pot esterification-click (CuAAC) study | |
Althagafi et al. | Chemoselective synthesis of isolated and fused fluorenones and their photophysical and antiviral properties | |
CN107641080A (en) | A kind of dihydronaphthalene ketones derivant containing spirane structure and preparation method thereof | |
CN109232515B (en) | Crown ether compound and its preparing method | |
Bravais et al. | Synthesis of 4‐hydroxy [4‐3H]‐2 (E)‐nonen‐1‐al‐diethylacetal | |
Nakatsuji et al. | Ethynologs of triphenylmethane dyes. Part 6. A simple and convenient synthesis of aryl-substituted push-pull butadienes from 1, 1-diaryl-2-propyn-1-ols. | |
JP2019509293A (en) | 4-Pentafluorothiophenol compounds and preparation method, and preparation method of pentafluorosulfur-substituted benzopyran compounds | |
Sasaki et al. | Synthesis of metal furoylacetonates and their SE reactions. I. Heteroaromaticity | |
CN110304982A (en) | A pyrenyl hexa-substituted benzene compound with aggregation-induced luminescence enhancement and its synthesis method and application | |
TWI833610B (en) | Method and intermediates for preparing tricyclic compounds | |
CN115716782B (en) | Synthesis method of multi-carbonyl compound | |
CN102617313A (en) | Sharing synthesis method for vanillin and isovanillin | |
CN118063294A (en) | Efficient preparation method of dapagliflozin intermediate | |
Naik et al. | 1, 5-diphenylpenta-1, 4 dien-3-ones: A novel class of free radical scavengers | |
CN109336748B (en) | Preparation method of NASH-resistant drug intermediate diformaldehyde magnolol | |
WATANABE et al. | Stable Sulfur Ylides. III. Reaction of Stable Sulfonium Allylides and Oxosulfonium Allylides with Alkoxides | |
INUBUSHI et al. | Alkaloids of the leaves of Cocculus laurifolius DC. II. The structure of Erythroculine | |
Misra et al. | DFT studies on the mechanism of base-catalyzed hydrocyanation of alpha, beta-unsaturated ketones |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |